Literature DB >> 30185508

Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children.

Dithi Banerjee1, Neena Kanwar1, Ferdaus Hassan1, Cynthia Essmyer2, Rangaraj Selvarangan3.   

Abstract

The rapid and accurate detection of influenza A virus (FluA), influenza B virus (FluB), and respiratory syncytial virus (RSV) improves patient care. Sample-to-answer (STA) platforms based on nucleic acid amplification and detection of these viruses are simple, automated, and accurate. We compared six such platforms for the detection of FluA, FluB, and RSV: Cepheid GeneXpert Xpress Flu/RSV (Xpert), Hologic Panther Fusion Flu A/B/RSV (Fusion), Cobas influenza A/B & RSV (Liat), Luminex Aries Flu A/B & RSV (Aries), BioFire FilmArray respiratory panel (RP), and Diasorin Simplexa Flu A/B & RSV (Simplexa). Nasopharyngeal (NP) swab specimens (n = 225) from children previously tested by RP were assessed on these platforms. The results were compared to those of the Centers for Disease Control and Prevention (CDC)-developed real-time reverse transcription-PCR (rRT-PCR) assay for influenza A/B viruses and RSV. Subtyping for FluA and FluB was performed for discrepant analysis where applicable. The percent sensitivities/specificities for FluA detection were 100/100 (Fusion), 98.6/99.3 (Xpert), 100/100 (Liat), 98.6/100 (Aries), 98.6/100 (Simplexa), and 100/100 (RP). The percent sensitivities/specificities for FluB detection were 100/100 (Fusion), 97.9/99.4 (Xpert), 97.9/98.3 (Liat), 93.7/99.4 (Aries), 85.4/99.4 (Simplexa), and 95.8/97.7 (RP); and those for RSV detection were 98.1/99.4 (Xpert), 98.1/99.4 (Liat), 96.3/100 (Fusion), 94.4/100 (Aries), 87/94.4 (Simplexa), and 94.4/100 (RP). The 75 strains confirmed to be FluA included 29 pH1N1, 39 H3N2, 4 sH1N1, and 3 untyped strains. The 48 strains confirmed to be FluB included 33 strains of the Yamagata lineage, 13 of the Victoria lineage, 1 of both the Yamagata and Victoria lineages, and 1 of an unknown lineage. All six STA platforms demonstrated >95% sensitivity for FluA detection, while three platforms (Fusion, Xpert, and Liat) demonstrated >95% sensitivity for FluB and RSV detection.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  FluA/B and RSV; clinical microbiology; sample to answer

Mesh:

Year:  2018        PMID: 30185508      PMCID: PMC6204686          DOI: 10.1128/JCM.00930-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

Review 1.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

2.  Performance of a commercial assay for the diagnosis of influenza A (H1N1) infection in comparison to the Centers for Disease Control and Prevention protocol of real time RT-PCR.

Authors:  María G Barbás; Sandra V Gallego; Gonzalo M Castro; Elsa Baumeister; Silvia Kademian; Juan De Leon; Analía Cudolá
Journal:  Rev Argent Microbiol       Date:  2012 Jan-Mar       Impact factor: 1.852

3.  Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples.

Authors:  Musa Hindiyeh; Liat Kolet; Tal Meningher; Merav Weil; Ella Mendelson; Michal Mandelboim
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Impact of Rapid Molecular Respiratory Virus Testing on Real-Time Decision Making in a Pediatric Emergency Department.

Authors:  Daniel T Rogan; Mohit S Kochar; Samuel Yang; James V Quinn
Journal:  J Mol Diagn       Date:  2017-03-22       Impact factor: 5.568

5.  Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.

Authors:  Daniel M Cohen; Jennifer Kline; Larissa S May; Glenn Eric Harnett; Jane Gibson; Stephen Y Liang; Zubaid Rafique; Carina A Rodriguez; Kevin M McGann; Charlotte A Gaydos; Donna Mayne; David Phillips; Jason Cohen
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

6.  Delayed RSV diagnosis in a stem cell transplant population due to mutations that result in negative polymerase chain reaction.

Authors:  Dana Hawkinson; Sunil Abhyankar; Omar Aljitawi; Siddhartha Ganguly; Joseph P McGuirk; Rebecca Horvat
Journal:  Diagn Microbiol Infect Dis       Date:  2013-02-14       Impact factor: 2.803

Review 7.  Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis.

Authors:  Caroline Chartrand; Nicolas Tremblay; Christian Renaud; Jesse Papenburg
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

8.  Performance of the molecular Alere I influenza A&B test compared to that of the xpert flu A/B assay.

Authors:  Kimberle C Chapin; Estefany J Flores-Cortez
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

9.  The performance of Luminex ARIES® Flu A/B & RSV and Cepheid Xpert® Flu/RSV XC for the detection of influenza A, influenza B, and respiratory syncytial virus in prospective patient samples.

Authors:  Phillip McMullen; Sue Boonlayangoor; Angella Charnot-Katsikas; Kathleen G Beavis; Vera Tesic
Journal:  J Clin Virol       Date:  2017-09-05       Impact factor: 3.168

10.  Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract Specimens.

Authors:  Stefan Juretschko; James Mahony; Richard S Buller; Ryhana Manji; Sherry Dunbar; Kimberly Walker; Arundhati Rao
Journal:  J Clin Microbiol       Date:  2017-05-24       Impact factor: 5.948

View more
  15 in total

1.  Impact of Rapid Molecular Detection of Respiratory Viruses on Clinical Outcomes and Patient Management.

Authors:  Jane Kuypers
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  Evaluation of the analytical performance and specificity of a SARS-CoV-2 transcription-mediated amplification assay.

Authors:  Markus Schneider; Thomas Iftner; Tina Ganzenmueller
Journal:  J Virol Methods       Date:  2021-05-10       Impact factor: 2.014

Review 3.  Cost-Effective Respiratory Virus Testing.

Authors:  B A Pinsky; R T Hayden
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

4.  Panther Fusion® Respiratory Virus Assays for the detection of influenza and other respiratory viruses.

Authors:  Kathleen A Stellrecht; Jesse L Cimino; Lisa I Wilson; Vincente P Maceira; Shafiq A Butt
Journal:  J Clin Virol       Date:  2019-11-09       Impact factor: 3.168

5.  Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study.

Authors:  Janette Rahamat-Langendoen; Hans Groenewoud; Judith Kuijpers; Willem J G Melchers; Gert Jan van der Wilt
Journal:  J Med Virol       Date:  2019-04-14       Impact factor: 2.327

Review 6.  An evolving approach to the laboratory assessment of COVID-19.

Authors:  Hongzhou Lu; Charles W Stratton; Yi-Wei Tang
Journal:  J Med Virol       Date:  2020-07-28       Impact factor: 20.693

7.  Performance evaluation of the Panther Fusion® respiratory tract panel.

Authors:  Jolanda J C Voermans; Daphne G J C Mulders; Suzan D Pas; Marion P G Koopmans; Annemiek A van der Eijk; Richard Molenkamp
Journal:  J Clin Virol       Date:  2019-12-10       Impact factor: 3.168

8.  Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples.

Authors:  Lola Folgueira; Noelia Moral; Consuelo Pascual; Rafael Delgado
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

9.  Point-of-care tests for influenza A and B viruses and RSV in emergency departments - indications, impact on patient management and possible gains by syndromic respiratory testing, Capital Region, Denmark, 2018.

Authors:  Uffe Vest Schneider; Mona Katrine Alberthe Holm; Didi Bang; Randi Føns Petersen; Shila Mortensen; Ramona Trebbien; Jan Gorm Lisby
Journal:  Euro Surveill       Date:  2020-11

10.  Retrospective study of clinical characteristics and viral etiologies of patients with viral pneumonia in Beijing.

Authors:  Xiang Zhao; Yao Meng; Duo Li; Zhaomin Feng; Weijuan Huang; Xiyan Li; Hejiang Wei; Xiaoxu Zeng; Dayan Wang
Journal:  Pulm Circ       Date:  2021-05-14       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.